Dengyue Medicine

Dengyue Medicine adicionou um novo artigo Health
2026-04-22 01:20:09

Tumor Treatment Enters the “Stratification Era”: KRAS, EGFR and Other Mutation-Driven Therapies Reshape the Anti-Cancer Landscape
From the “one-size-fits-all” approach of chemotherapy and radiotherapy to today’s “tailor-made” precision medicine, cancer treatment has officially entered the “stratification era.” Diseases are no longer defined simply by the site of origin, but by decoding molecular characteristics and identifying key driver mutations that fuel tumor growth. ...

0 Comentários 0 Compartilhamentos 273 Visualizações 0 Anterior

Faça Login para curtir, compartilhar e comentar!
Dengyue Medicine adicionou um novo artigo Health
2026-04-21 07:46:24

Breaking the Bottleneck of Traditional Single-Payload ADCs: HK815, a TROP2 Dual-Payload ADC by HKBio, Leads the Next Generation of Cancer Therapy
Antibody-drug conjugates (ADCs) have become a major direction in precision oncology and, in recent years, have emerged as another high-growth therapeutic class following PD-1 inhibitors. From Trodelvy to Datopotamab Deruxtecan, multiple TROP2-targeting ADCs have demonstrated promising efficacy in solid tumors such as breast cancer and lung cancer. However, with deeper clinical...

0 Comentários 0 Compartilhamentos 277 Visualizações 0 Anterior

Faça Login para curtir, compartilhar e comentar!
Dengyue Medicine adicionou um novo artigo Health
2026-04-21 01:22:48

Cell Therapy in Autoimmune Diseases: Treatment Options for Rheumatoid Arthritis and Lupus
Autoimmune diseases refer to conditions in which the immune system mistakenly attacks the body’s own tissues, leading to chronic inflammation and progressive organ damage. Among them, Rheumatoid Arthritis and Systemic Lupus Erythematosus are among the most severe in clinical practice. Despite advances in biologic therapies and immunosuppressants, many patients still face disease...

0 Comentários 0 Compartilhamentos 444 Visualizações 0 Anterior

Faça Login para curtir, compartilhar e comentar!
Dengyue Medicine adicionou um novo artigo Health
2026-04-20 08:51:31

Gene Therapy Enters Clinical Practice: Rare Neurological Diseases Usher in a New Era of Precision Treatment
Against the backdrop of modern medicine rapidly advancing toward precision and personalization, gene therapy is accelerating from proof-of-concept to clinical application, emerging as a key frontier in global pharmaceutical innovation. In particular, in the field of rare neurological disorders represented by Huntington's disease, gene therapy is enabling a shift from “symptom...

0 Comentários 0 Compartilhamentos 298 Visualizações 0 Anterior

Faça Login para curtir, compartilhar e comentar!
Dengyue Medicine adicionou um novo artigo Health
2026-04-16 07:58:34

Hanlikang® Gains Approval for Two New NHL Indications, Expanding Full-Course Treatment Coverage in DLBCL
Against the backdrop of continuous advancements in lymphoma treatment in China, domestic biosimilars are steadily expanding their clinical boundaries. On April 9, Shanghai Henlius Biotech announced that its rituximab injection Hanlikang® (HLX01) has received approval from the National Medical Products Administration for two new indications in non-Hodgkin lymphoma (NHL), further...

0 Comentários 0 Compartilhamentos 316 Visualizações 0 Anterior

Faça Login para curtir, compartilhar e comentar!
Dengyue Medicine adicionou um novo artigo Health
2026-04-15 06:09:45

Neuroinflammation in Neurodegenerative Diseases: New Insights and Therapeutic Targets
Neuroinflammation has emerged as a central pathogenic driver in a wide range of neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis (ALS), and multiple sclerosis. Chronic glial activation and dysregulated immune signaling were once considered merely secondary consequences of neuronal loss, but are now recognized as...

0 Comentários 0 Compartilhamentos 327 Visualizações 0 Anterior

Faça Login para curtir, compartilhar e comentar!
Dengyue Medicine adicionou um novo artigo Health
2026-04-14 01:34:52

The Era of “Precision + Combination Therapy”: Reshaping the Paradigm of Cancer Treatment
With continuous breakthroughs in molecular biology and tumor immunology, cancer treatment is undergoing a critical transition from a “single-drug-driven” model to a “systemic therapeutic strategy.” Precision medicine based on biomarkers, combined with multi-mechanism synergistic therapies, is gradually becoming a key approach to improving efficacy and extending...

0 Comentários 0 Compartilhamentos 542 Visualizações 0 Anterior

Faça Login para curtir, compartilhar e comentar!
Dengyue Medicine adicionou um novo artigo Health
2026-04-13 08:48:11

Six Major Trends in the Global Pharmaceutical Market: Structural Reshaping and New Growth Logic
Against the backdrop of changing global demographics, evolving disease patterns, and continuous technological advancement, the pharmaceutical industry is entering a new phase characterized by both deep adjustment and accelerated evolution. Compared with the past single-dimensional growth logic, today’s global pharmaceutical market is showing a multi-trend, overlapping development...

0 Comentários 0 Compartilhamentos 426 Visualizações 0 Anterior

Faça Login para curtir, compartilhar e comentar!
Dengyue Medicine adicionou um novo artigo Health
2026-04-11 09:06:44

Global Pharma M&A Enters a Structural Acceleration Phase: Where Will the 2026 Mega Deals Concentrate?
The global pharmaceutical industry is entering a structural acceleration phase of M&A, rather than a simple cyclical upswing. The core driver has shifted from periods of abundant capital and occasional mega-deals to persistent growth anxiety. As the patent cliff approaches in a concentrated wave, while the development cycle for innovative drugs has not significantly shortened,...

0 Comentários 0 Compartilhamentos 557 Visualizações 0 Anterior

Faça Login para curtir, compartilhar e comentar!
Dengyue Medicine adicionou um novo artigo Health
2026-04-09 09:34:31

From “Single-Drug Breakthroughs” to “Platform Dominance”: The Comprehensive Restructuring of Global Innovative Drug Competition and Commercialization Systems
For a long time, the global pharmaceutical industry followed a relatively clear development path—driven by single blockbuster drugs. A successful drug could sustain a company’s growth for years, even over a decade. From statins to PD-1/PD-L1 immunotherapies, this model has been repeatedly validated across different eras. However, after 2025, this logic is undergoing profound...

0 Comentários 0 Compartilhamentos 548 Visualizações 0 Anterior

Faça Login para curtir, compartilhar e comentar!

Mais Stories

Connect Freelancing Platform